Aigen Investment Management’s Valero Energy VLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Sell
7,638
-1,279
-14% -$315K 0.54% 43
2026
Q1
$2.2M Buy
+8,917
New +$1.84M 0.57% 38
2025
Q4
Sell
-8,662
Closed -$1.47M 1006
2025
Q3
$1.47M Buy
8,662
+5,189
+149% +$774K 0.23% 118
2025
Q2
$467K Buy
3,473
+1,441
+71% +$180K 0.06% 418
2025
Q1
$268K Buy
+2,032
New +$270K 0.04% 538
2023
Q2
Sell
-44,141
Closed -$6.16M 978
2023
Q1
$6.16M Buy
+44,141
New +$5.93M 0.85% 21
2022
Q3
Sell
-10,144
Closed -$1.08M 780
2022
Q2
$1.08M Buy
+10,144
New +$1.2M 0.18% 161
2020
Q4
Sell
-28,545
Closed -$1.24M 1089
2020
Q3
$1.24M Buy
28,545
+12,099
+74% +$634K 0.16% 209
2020
Q2
$967K Buy
16,446
+1,698
+12% +$101K 0.12% 271
2020
Q1
$669K Sell
14,748
-5,205
-26% -$378K 0.09% 330
2019
Q4
$1.87M Buy
+19,953
New +$1.89M 0.31% 74

Other funds holding VLO

Aigen Investment Management's VLO Position: Q2 2026 in Review

Aigen Investment Management reduced its Valero Energy (VLO) stake by 14% in Q2 2026, selling an estimated $315K and leaving 7,638 shares worth $1.99M. The position accounts for 0.54% of the portfolio, ranked #43.

Aigen Investment Management first reported a position in VLO in Q4 2019 and has held it in 11 quarters since. The position peaked at $6.16M in Q1 2023. 1,979 funds tracked by Wall St. Rank hold VLO as of Q2 2026.

  • Aigen Investment Management held 7,638 shares of Valero Energy worth $1.99M as of Q2 2026.
  • Aigen Investment Management sold 1,279 Valero Energy shares in Q2 2026, an estimated $315K.
  • Valero Energy made up 0.54% of Aigen Investment Management's portfolio in Q2 2026, its #43 holding.
  • Aigen Investment Management first reported a position in Valero Energy in Q4 2019 and has held it in 11 quarters since.
  • Aigen Investment Management's Valero Energy position peaked at $6.16M in Q1 2023.
  • 1,979 funds tracked by Wall St. Rank held Valero Energy as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.